Winfield Associates’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-705
Closed -$31K 567
2017
Q4
$31K Buy
705
+10
+1% +$461 0.02% 242
2017
Q3
$35K Hold
695
0.02% 223
2017
Q2
$33K Hold
695
0.02% 223
2017
Q1
$31K Hold
695
0.02% 222
2016
Q4
$28K Buy
695
+120
+21% +$4.73K 0.02% 226
2016
Q3
$22K Buy
575
+5
+0.9% +$201 0.01% 241
2016
Q2
$24K Sell
570
-40
-7% -$1.64K 0.02% 238
2016
Q1
$24K Buy
+610
New +$24.5K 0.02% 228

Other funds holding SNY

Winfield Associates's SNY Position: Q1 2018 in Review

Winfield Associates sold out of Sanofi (SNY) in Q1 2018, closing a stake of 705 shares — an estimated $31K sold.

Winfield Associates first reported a position in SNY in Q1 2016 and held it in 8 quarters. The position peaked at $35K in Q3 2017. 487 funds tracked by Wall St. Rank hold SNY as of Q1 2018.

  • Winfield Associates reported no remaining Sanofi position as of Q1 2018 after selling out during the quarter.
  • Winfield Associates sold 705 Sanofi shares in Q1 2018, an estimated $31K.
  • Winfield Associates first reported a position in Sanofi in Q1 2016 and held it in 8 quarters.
  • Winfield Associates's Sanofi position peaked at $35K in Q3 2017.
  • 487 funds tracked by Wall St. Rank held Sanofi as of Q1 2018.

Based on Winfield Associates's 13F filing for Q1 2018, filed 10 May 2018.